Somaxon Raises $65M

San Diego-based Somaxon Pharmaceuticals has raised $65M in funding developing its products for the treament of insomnia and other neuro-pyschiatric disorders. The company said that its Series C was led by MPM Capital Partners, and included new investor Prospect Ventures. Existing investors Domain Associates, BA Venture Partners, Montreux Equity Partners and CDIB BioScience Ventures also particpated. Kurt Wheller and Ilan Zipkin of MPM have joined the board. More information »